AngioDynamics, Inc. (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (RFA) systems, NanoKnife Ablation Systems, surgical resection systems and embolization products for treating benign and malignant tumors. It designs, develops, manufactures and markets a line of therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors, and other non-coronary diseases. The Company operates in three segments: Peripheral Vascular, Access and Oncology/Surgery. The Peripheral Vascular segment consists of its venous, angiographic, percutaneous transluminal angioplasty, drainage and thrombolytic product lines. The Access segment consists of its dialysis, ports and PICC product lines. The Oncology/Surgery segment consists of its RFA, embolization, Habib and NanoKnife product lines.